Dr. ibm Watson (IBM Watson partnered with contrast Company Prostate AI)

Benshaw found that many of his friends were interested in the information about the cooperation between IBM Watson and comparison on Prostate AI. Benshaw compiled some information about the cooperation between IBM Watson and comparison in prostate AI and shared it here.

To develop and sell artificial intelligence algorithms for diagnosing prostate cancer in MRI scans, IBM Watson Health is working with Guerbet, a French manufacturer of medical imaging contrast agents.

The agreement is based on the previously co-developed liver cancer diagnosis AI software.

Dr. David David Glenn, IBM Watson Medical Imaging's chief medical officer, said in a statement: "identifying lies related to prostate cancer requires rapid treatment of cancer and major diagnostic challenges that only require active monitoring while avoiding unnecessary biopsies.

Achieving optimal patient outcomes depends on "the rapid and accurate diagnosis and treatment that artificial intelligence technology may help provide," Gruen added. "

Guerbet CEO Fran oisNicolas said that like the existing liver cancer collaboration program, the new project aims to provide enhanced intelligence to help radiologists and oncologists.

Nicolas said the move was in line with Guerbet's mission to develop "ambitious medical solutions to speed up diagnosis, improve patient experience and reduce clinical risks and costs".